Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer

Clinical trial NCT00753844 · COMPLETED

Trial details

NCT number: NCT00753844
Sponsor: Kinki University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 2006-11-01
Primary completion: 2009-06-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.